Although studies investigating the effects of G. biloba in cerebral insufficiency, a syndrome that is often characterised by depression, have shown positive results, no clinical studies are available that have investigated its use in clinical depression.

One randomised, double-blind placebo-controlled study has investigated its effects in seasonal affective disorder (SAD). Ginkgo biloba extract PN246, in tablet form (Bio-Biloba), was tested in 27 patients with SAD over 10 weeks or until they developed symptoms, starting in a symptom-free phase about 1 month before symptoms were expected. In this trial, G. biloba failed to prevent the development of SAD (Lingaerde et al 1999).

© 2007 Elsevier Australia

More recently, Cleza et al (2003) tested EGb 761 (240 mg/day) on the subjective emotional well-being of healthy older subjects (50-65 years) in a randomised, double-blind study. Ginkgo treatment produced a statistically significant difference for the VAS mental health and for QOL, as well as for the Subjective Intensity Score Mood in week 2 compared with placebo. At the end of the study, statistically significant improvement in the EGb 761 group was observed for the variables: depression, fatigue and anger.

Beat Depression Now

Beat Depression Now

Let me be up front. My intention is to sell you something. Normally, it's not wise to come out and say that. However, I can do so because I have such an incredible deal for you that you'd be crazy to pass on it.

Get My Free Ebook

Post a comment